Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | Rho-associated, coiled-coil containing protein kinase 2 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | aryl hydrocarbon receptor | 0.0015 | 0.0056 | 0.0148 |
Treponema pallidum | ATP-dependent RNA helicase | 0.0212 | 0.3752 | 0.5 |
Leishmania major | protein kinase, putative | 0.0015 | 0.0063 | 0.0039 |
Trypanosoma brucei | Eukaryotic initiation factor 4A-1 | 0.0212 | 0.3752 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0212 | 0.3752 | 0.3752 |
Trypanosoma cruzi | STE group serine/threonine-protein kinase, putative | 0.0015 | 0.0063 | 0.0039 |
Trypanosoma cruzi | PAS-domain containing phosphoglycerate kinase, putative | 0.0015 | 0.0056 | 0.002 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0176 | 0.3068 | 0.8178 |
Trypanosoma cruzi | PAS-domain containing phosphoglycerate kinase, putative | 0.0015 | 0.0056 | 0.002 |
Onchocerca volvulus | Eukaryotic initiation factor 4A homolog | 0.0212 | 0.3752 | 0.7694 |
Schistosoma mansoni | single-minded | 0.0057 | 0.0846 | 0.2255 |
Echinococcus granulosus | eukaryotic initiation factor 4A III | 0.0212 | 0.3752 | 1 |
Plasmodium vivax | RNA helicase-1, putative | 0.0212 | 0.3752 | 0.5 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0212 | 0.3752 | 1 |
Chlamydia trachomatis | two component regulatory system sensor histidine kinase | 0.0015 | 0.0056 | 0.5 |
Onchocerca volvulus | 0.0175 | 0.3061 | 0.6278 | |
Plasmodium falciparum | eukaryotic initiation factor 4A | 0.0212 | 0.3752 | 0.5 |
Echinococcus multilocularis | rho associated protein kinase | 0.0176 | 0.3068 | 0.8178 |
Onchocerca volvulus | 0.0042 | 0.0569 | 0.1166 | |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.0272 | 0.4876 | 0.4876 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0212 | 0.3752 | 1 |
Onchocerca volvulus | 0.0176 | 0.3068 | 0.6293 | |
Mycobacterium ulcerans | putative regulatory protein | 0.0042 | 0.0569 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0056 | 0.0056 |
Brugia malayi | hypoxia-induced factor 1 | 0.0177 | 0.3084 | 0.3084 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.0015 | 0.0063 | 0.0039 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0212 | 0.3752 | 1 |
Brugia malayi | Pax transcription factor protein 2 | 0.0272 | 0.4876 | 0.4876 |
Mycobacterium leprae | Possible regulatory protein | 0.0015 | 0.0056 | 0.5 |
Onchocerca volvulus | 0.0272 | 0.4876 | 1 | |
Entamoeba histolytica | DEAD/DEAH box helicase, putative | 0.0212 | 0.3752 | 0.5 |
Brugia malayi | hypothetical protein | 0.0191 | 0.3362 | 0.3362 |
Loa Loa (eye worm) | aryl Hydrocarbon receptor Associated protein family member | 0.0015 | 0.0056 | 0.0056 |
Giardia lamblia | Translation initiation factor eIF-4A, putative | 0.0212 | 0.3752 | 0.5 |
Toxoplasma gondii | eukaryotic initiation factor-4A, putative | 0.0212 | 0.3752 | 0.5 |
Echinococcus granulosus | eukaryotic initiation factor 4A | 0.0212 | 0.3752 | 1 |
Echinococcus multilocularis | eukaryotic initiation factor 4A | 0.0212 | 0.3752 | 1 |
Loa Loa (eye worm) | hypoxia-induced factor 1 | 0.0177 | 0.3084 | 0.3084 |
Echinococcus granulosus | rho-associated protein kinase 1 | 0.0176 | 0.3068 | 0.8178 |
Echinococcus granulosus | aryl hydrocarbon receptor | 0.0015 | 0.0056 | 0.0148 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0212 | 0.3752 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0191 | 0.3362 | 0.3362 |
Onchocerca volvulus | 0.0015 | 0.0056 | 0.0114 | |
Echinococcus multilocularis | transfer RNA-Lys | 0.0042 | 0.0569 | 0.1516 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0212 | 0.3752 | 1 |
Echinococcus multilocularis | Aryl hydrocarbon receptor nuclear | 0.0015 | 0.0056 | 0.0148 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0014 | 0.0048 | 0.0048 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0212 | 0.3752 | 1 |
Leishmania major | protein kinase, putative | 0.0015 | 0.0063 | 0.0039 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0212 | 0.3752 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0014 | 0.0048 | 0.0048 |
Schistosoma mansoni | aryl hydrocarbon receptor | 0.0057 | 0.0846 | 0.2255 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0014 | 0.0048 | 0.0048 |
Leishmania major | PAS-domain containing phosphoglycerate kinase, putative | 0.0015 | 0.0056 | 0.002 |
Mycobacterium tuberculosis | Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) | 0.0212 | 0.3752 | 0.5 |
Echinococcus multilocularis | eukaryotic initiation factor 4A III | 0.0212 | 0.3752 | 1 |
Brugia malayi | bHLH-PAS transcription factor | 0.0042 | 0.0569 | 0.0569 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0212 | 0.3752 | 1 |
Trypanosoma cruzi | STE group serine/threonine-protein kinase, putative | 0.0015 | 0.0063 | 0.0039 |
Loa Loa (eye worm) | AGC/DMPK/ROCK protein kinase | 0.0546 | 1 | 1 |
Brugia malayi | PAS domain containing protein | 0.0057 | 0.0846 | 0.0846 |
Brugia malayi | eukaryotic initiation factor 4A | 0.0212 | 0.3752 | 0.3752 |
Brugia malayi | Cytochrome P450 family protein | 0.0014 | 0.0048 | 0.0048 |
Echinococcus granulosus | Aryl hydrocarbon receptor nuclear | 0.0015 | 0.0056 | 0.0148 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.0015 | 0.0063 | 0.0039 |
Echinococcus granulosus | single minded 2 | 0.0042 | 0.0569 | 0.1516 |
Brugia malayi | Cytochrome P450 family protein | 0.0014 | 0.0048 | 0.0048 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0212 | 0.3752 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.